Adelaide: RHS Limited (ASX: RHS) (“RHS” or “the Company”) is pleased to announce that the scheme of arrangement between RHS and its shareholders (“Scheme”) has today been implemented. Implementation follows approval of the Scheme by RHS shareholders at the Scheme meeting held on 22 May 2018 and by the Federal Court of Australia on 29 […]
COPAS Vision, our newest large particle flow cytometer, adds brightfield imaging to our large particle sorting capabilities. As with our original COPAS platform of flow cytometers it provides automated high throughput analysis and sorting of viable multicellular organisms, cell clusters, bead-based libraries and other samples that are too large or too fragile for traditional flow […]
Vienna, Austria, and Rijswijk, The Netherlands – Lexogen, a transcriptomics and next-generation sequencing company and Bluebee, a global bioinformatics platform, have announced today the implementation of QuantSeq Unique Molecular Identifiers (UMI) data analysis pipeline on the Bluebee genomics analysis platform. This collaboration offers QuantSeq users utilizing UMIs the opportunity to analyze samples in a convenient and rapid manner […]
Oxford, UK. Oxford Gene Technology (OGT), The Molecular Genetics Company, has expanded its SureSeq myPanel™ NGS Custom Cancer Panel content – now covering 120 fully optimised cancer related genes. The expanded content gives researchers even more freedom to customise their sequencing experiments, enabling focus on regions of interest, saving time and cost. As well as proactive updates, this expansion […]
BILLERICA, Mass. — Bruker today announced the launch of the SKYSCAN™ 2214, a multiscale X-ray nano-CT (computed tomography) system with a unique X-ray source and detector geometry that generates sharper images with outstanding precision. The SKYSCAN 2214 offers unprecedented, ultra-high resolution for larger fields of view in larger objects, which makes nano-CT practical and truly useful for industrial and […]
To promote the Cancer Research Institute’s global awareness campaign, Cancer Immunotherapy Month, ACEA Biosciences will be participating in the #WearWhite campaign on June 15 and providing an Immunotherapy Research Grant to help scientists in the field of cancer research achieve their goals. As a leading innovator in the development of tools for the cancer research […]
Under this agreement, MaxCyte’s second signed with a U.S. NIH institute in the past year, the Company and the National Heart, Lung, and Blood Institute will explore development of new therapies for sickle cell disease using MaxCyte’s gene-correction platform Gaithersburg, Maryland – MaxCyte, Inc. today announces it has entered into a Cooperative Research and Development Agreement (“CRADA”) […]
New publication maps ligase fidelity profiles with single molecule real-time sequencing to enable 20+ fragment assemblies with high efficiency and accuracy IPSWICH, MA, USA — Some of today’s most exciting molecular biology engineering — including the creation of customized CRISPR/Cas9 and TALEN constructs for genome editing — are led by synthetic biologists. These scientists are […]
Utrecht, The Netherlands Continuing its customer-centric approach, and fulfilling its commitment to providing preclinical imaging systems of unmatched price/performance, MILabs has introduced its E-Class of tomographic imaging products. The E-Class imagers were specifically designed for ambitious researchers to start their research now, and who want the option to easily upgrade the same system in the […]
SINGAPORE – Sengenics, the functional proteomics company, today announced the retail product launch of two new protein microarrays, the IMMUNOME™ v4 Discovery Array and the CTA Array which are now available for purchase for the very first time by any researcher. Both these arrays use the patented Sengenics KREX™ functional proteomics technology that ensures that […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
